Weiss Ratings Reaffirms Hold (C) Rating for Henry Schein (NASDAQ:HSIC)

Key Points

• Weiss Ratings has reiterated a "hold (c)" rating for Henry Schein (NASDAQ:HSIC), alongside a consensus price target of $76.67 from various analysts.
• The company's stock has seen a slight decrease of 0.2%, with recent price targets from analysts ranging from $70.00 to $83.00.
• Henry Schein reported $1.10 EPS for the last quarter, missing estimates by $0.09, while its revenue increased by 3.3% year-over-year.

Henry Schein (NASDAQ:HSIC - Get Free Report)'s stock had its "hold (c)" rating reiterated by stock analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

A number of other analysts also recently commented on HSIC. Stifel Nicolaus reiterated a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Evercore ISI upgraded shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a report on Tuesday, August 26th. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Barrington Research reiterated an "outperform" rating and issued a $78.00 price objective on shares of Henry Schein in a report on Tuesday, September 23rd. Finally, UBS Group cut their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $76.67.

Henry Schein Stock Down 0.2%

HSIC opened at $64.73 on Wednesday. Henry Schein has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $67.64 and a 200 day moving average price of $68.89. The company has a market cap of $7.85 billion, a PE ratio of 20.88, a price-to-earnings-growth ratio of 2.14 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm's revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts expect that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Institutional Trading of Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Central Pacific Bank Trust Division increased its holdings in shares of Henry Schein by 2.7% during the 3rd quarter. Central Pacific Bank Trust Division now owns 11,300 shares of the company's stock worth $750,000 after buying an additional 300 shares during the last quarter. Squarepoint Ops LLC increased its holdings in Henry Schein by 724.4% in the 2nd quarter. Squarepoint Ops LLC now owns 46,841 shares of the company's stock valued at $3,422,000 after purchasing an additional 41,159 shares during the last quarter. Thompson Davis & CO. Inc. acquired a new stake in Henry Schein in the 2nd quarter valued at approximately $1,262,000. Westwood Holdings Group Inc. acquired a new stake in Henry Schein in the 2nd quarter valued at approximately $20,631,000. Finally, CYBER HORNET ETFs LLC acquired a new stake in Henry Schein in the 2nd quarter valued at approximately $25,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.